Ignite Creation Date:
2024-07-17 @ 10:48 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06470607
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-06-17
Brief Title:
The Lymphocytic Infiltrate of Lung Tumors
Sponsor:
Scientific Institute San Raffaele
Organization:
Scientific Institute San Raffaele
Study Overview
Official Title:
Biological Observational Monocentric Study Aimed at Analyzing the Lymphocytic Infiltrate of Lung Tumors
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TREGILC
Brief Summary:
The study is configured as a monocentric observational transversal biological study
The main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity in particular non-small cell lung cancer NSCLC
The study involves the collection of clinical data and biological material blood and tumor tissue from 70 subjects diagnosed with thoracic tumors
The main objective of the study is the reconstruction of the molecular organization of tumors of the thoracic cavity in particular non-small cell lung cancer NSCLC
The study involves the collection of clinical data and biological material blood and tumor tissue from 70 subjects diagnosed with thoracic tumors
Detailed Description:
Inclusion criteria
The study population will include all patients with the following characteristics
Ability to provide informed consent Men and women over the age of 18 Patients candidates for surgical treatment diagnosed with thoracic tumors
The procedures to which the patient will undergo during the study follow the standard of clinical practice for the treatment of pathology
Exclusion criteria
Previous chemotherapy for any cancer within the last 6 months Pregnant andor breastfeeding women Immunosuppressive state states of immunosuppression or ongoing immunosuppressiveimmunomodulatory treatments
The time of observation of the patient for the purposes of the study is limited to the time of hospitalization and the surgical procedure the patient will therefore perform a single visit to the hospital and there is no provision for the collection of further data following discharge The study involves a single timepoint of data collection and samples
The study will have a total duration of 3 years
The study population will include all patients with the following characteristics
Ability to provide informed consent Men and women over the age of 18 Patients candidates for surgical treatment diagnosed with thoracic tumors
The procedures to which the patient will undergo during the study follow the standard of clinical practice for the treatment of pathology
Exclusion criteria
Previous chemotherapy for any cancer within the last 6 months Pregnant andor breastfeeding women Immunosuppressive state states of immunosuppression or ongoing immunosuppressiveimmunomodulatory treatments
The time of observation of the patient for the purposes of the study is limited to the time of hospitalization and the surgical procedure the patient will therefore perform a single visit to the hospital and there is no provision for the collection of further data following discharge The study involves a single timepoint of data collection and samples
The study will have a total duration of 3 years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None